Know-Legal Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Alza - Wikipedia

    en.wikipedia.org/wiki/ALZA

    Founded in 1968 by Dr. Alejandro Zaffaroni; the company's name is a portmanteau of his name. Alza was a major pioneer in the field of drug delivery systems, bringing over 20 prescription pharmaceutical products to market, and employing about 10,000 people during 20 years. [ 2] In 2001, Alza was acquired by Johnson & Johnson via a stock-for ...

  3. Osmotic-controlled release oral delivery system - Wikipedia

    en.wikipedia.org/wiki/Osmotic-controlled_Release...

    The osmotic-controlled release oral delivery system (OROS) is an advanced controlled release oral drug delivery system in the form of a rigid tablet with a semi-permeable outer membrane and one or more small laser drilled holes in it. As the tablet passes through the body, water is absorbed through the semipermeable membrane via osmosis, and ...

  4. Alza Corporation - Wikipedia

    en.wikipedia.org/?title=Alza_Corporation&redirect=no

    Language links are at the top of the page across from the title.

  5. Martin Gerstel - Wikipedia

    en.wikipedia.org/wiki/Martin_Gerstel

    He founded ALZA Corp at which he was a chief executive and financial officer. [3] [4] He is the chairman of Compugen (Israeli company) , Evogene , Keddem Bioscience, Mada Ltd. Gerstel is the co-founder and co-chairman of Itamar Medical , and serves as a director of Yissum Research Development Company of Hebrew University Ltd., Yeda Ltd. and the ...

  6. Modified-release dosage - Wikipedia

    en.wikipedia.org/wiki/Modified-release_dosage

    Modified-release dosage. Modified-release dosage is a mechanism that (in contrast to immediate-release dosage) delivers a drug with a delay after its administration (delayed-release dosage) or for a prolonged period of time (extended-release [ER, XR, XL] dosage) or to a specific target in the body (targeted-release dosage). [ 1]

  7. FDA approves Incyte's treatment for chronic graft-versus-host ...

    www.aol.com/fda-approves-incytes-treatment...

    August 14, 2024 at 3:49 PM. (Reuters) -The U.S. Food and Drug Administration on Wednesday approved drugmaker Incyte Corp's treatment for a type of graft-versus-host disease (GvHD). The drug ...

  8. Heller Ehrman - Wikipedia

    en.wikipedia.org/wiki/Heller_Ehrman

    Heller Ehrman headquarters at 333 Bush St., San Francisco, CA. 7 Times Square Tower, home of Heller Ehrman's New York City office. Heller Ehrman LLP was an international law firm of more than 730 attorneys in 15 offices in the United States, Europe, and Asia. Heller Ehrman was founded in San Francisco in 1890 and had additional offices located ...

  9. Alza.cz - Wikipedia

    en.wikipedia.org/wiki/Alza.cz

    Alza.cz a.s. is an e-commerce store operating in the Czech Republic, Slovakia (Alza.sk), and since 2014, in other European Union countries (Alza.de, Alza.at, Alza.hu, Alza.co.uk, Alzashop.com). [1] It's one of the largest online consumer electronics retailers in Central Europe with a strong stance in the toys, hobby, media and entertainment ...